Sevimli Nurgül, Yapar Dilek, Türktaş Haluk
Department of Chest Diseases, Gazi University School of Medicine, Ankara, Turkey.
Department of Public Health, Gazi University School of Medicine, Ankara, Turkey.
Turk Thorac J. 2019 Jan 31;20(2):97-102. doi: 10.5152/TurkThoracJ.2018.18055. Print 2019 Apr.
Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) is defined as a persistent airflow limitation with features of both asthma and COPD. However, in Turkey, there are limited data about ACO. The aims of the present study were to determine the prevalence of ACO among patients with asthma, to compare the clinical characteristics of patients with ACO and asthma, and to determine the threshold values for the diagnosis of ACO.
The study group comprised 338 patients admitted to the outpatient clinics between 2010 and 2017 and who had undergone at least three pulmonary function tests within the last 2 years. Patients aged >40 years with a smoking history of >10 pack-years or biomass exposure, with at least three features of both diseases, and with reversible and persistent airflow limitation were diagnosed with ACO. The study is a retrospective study so we did not get informed concent.
Asthma-chronic obstructive pulmonary disease overlap was diagnosed in 40 (11.8%) patients. Patients with ACO had fewer allergic comorbidities, worse spirometric parameters, and required higher doses of inhaled corticosteroids than patients with asthma only (p<0.05). No significant differences were observed between the groups regarding survival or number of hospitalizations and attacks (p>0.05). Threshold values were determined as age ≥57.5 years, smoking history ≥14 pack-years, and diagnosis at age ≥40.5 years.
The frequency of ACO was observed to be very high in patients with asthma. In patients >57.5 years old, with a smoking history of >14.5 pack-years, and diagnosed with asthma at >40.5 years old, the probability of ACO diagnosis increases.
哮喘-慢性阻塞性肺疾病重叠综合征(ACO)定义为具有哮喘和慢性阻塞性肺疾病(COPD)特征的持续性气流受限。然而,在土耳其,关于ACO的数据有限。本研究的目的是确定哮喘患者中ACO的患病率,比较ACO患者和哮喘患者的临床特征,并确定ACO诊断的阈值。
研究组包括2010年至2017年期间在门诊就诊且在过去2年内至少进行过三次肺功能测试的338例患者。年龄>40岁、吸烟史>10包年或有生物质暴露史、同时具有两种疾病的至少三个特征且存在可逆性和持续性气流受限的患者被诊断为ACO。本研究为回顾性研究,因此未获得知情同意。
40例(11.8%)患者被诊断为哮喘-慢性阻塞性肺疾病重叠综合征。与仅患哮喘的患者相比,ACO患者的过敏性合并症较少,肺功能参数较差,且需要更高剂量的吸入性糖皮质激素(p<0.05)。两组在生存率、住院次数和发作次数方面未观察到显著差异(p>0.05)。阈值确定为年龄≥57.5岁、吸烟史≥14包年以及在年龄≥40.5岁时确诊。
观察到哮喘患者中ACO的发生率非常高。年龄>57.5岁、吸烟史>14.5包年且在>40.5岁时被诊断为哮喘的患者,ACO诊断的可能性增加。